ADITEC’s Scientific and Socio-Economic Impact Report Thomson Reuters Impact Report Published The ADITEC Scientific and Socio-Economic Impact Report by Thomson Reuters, first presented at the European Parliament (click here for the Press Release) and during the H2020 Health Program Committee […]
We are pleased to inform you about the new training module “Advanced Course in Flow Cytometry Applied to Vaccinology” organised by University of Siena within the ADITEC project, and directed by Sandra Nuti (Head of GSK Vaccines R&D Center FACS […]
Recognizing some of the most significant medical discoveries from around the world, The Gairdner Foundation has awarded Dr. Rino Rappuoli, Chief Scientist and Head External R&D at GSK Vaccines, Siena, Italy, with the 2017 Canada Gairdner Award. One of seven […]
ADITEC is pleased to announce that the 2017 Albert B. Sabin Gold Medal award has been presented to Dr. Jan Holmgren for his pioneering contributions to oral vaccine research and mucosal immunology, as well as his leadership in the discovery […]
The next ADITEC Annual Meeting will be held in Siena (Italy), from the 18th till the 20th of September 2017.
The first report on comparative systems biology analysis of these four adjuvants was produced. The results of whole genome transcriptional analysis unrevealed common and unique molecular pathways and cellular responses induced by the different human adjuvants that could inform rational […]
Dear ADITEC Partner and Associates, We wish you and your families a Merry Christmas and a very Happy New Year. We take the opportunity to thank everyone for the great collaboration and achievements in the ADITEC project and we look […]
The ADITEC Project on Advanced Immunization Technologies: an European Success Story. 30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines. The ADITEC project was presented today at the European Parliament as a […]
The European Parliament holds an event on “Vaccine Research and Development in Europe” highlighting the ADITEC success story The Science and Technology Options Assessment (STOA) of the European Parliament, organizes an event “Working Breakfast on Vaccine Research and Development in […]
The ADITEC Project on Advanced Immunization Technologies: an European Success Story. 30 million Euros of funding, 42 public and private institutions have joined forces for next generation vaccines. The ADITEC project was presented today at the European Parliament as a […]